Figure 5A; Table S2. Me6I2-BODIPY-OT 5 on hOTR. Text: '3- to 9-fold rightward shift in EC50 compared to OT'.
- Measure
- EC50
- Value
- =5
- Target
- Homo sapiens
- Assay
- Not reported by source
Angewandte Chemie (International Ed. in English) · 2026
Sequence evidence
CYIQNCPLG
CYIQNCPLG
Experimental observations
Figure 5A; Table S2. Me6I2-BODIPY-OT 5 on hOTR. Text: '3- to 9-fold rightward shift in EC50 compared to OT'.
Figure 5D; Table S3. Me6I2-BODIPY-OT 5* on hOTR. Text: 'only a minor increase in activity (~2-fold)'.
Figure 5F. Me6I2-BODIPY-OT 5 at 100 nM on hV1aR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. Me6I2-BODIPY-OT 5 at 100 nM on hV1bR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 4. Me6I2-BODIPY-OT 5 in MTT assay. Text: 'except for 1 uM 5' exhibited higher cell viability than unmodified OT.
Figure 4. Me6I2-BODIPY-OT 5* in MTT assay. Text: 'The uncaged compound mixtures exhibited values comparable to those of OT'.
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.